STANDARD BIOTOOLS INC

Standard Biotools Inc. specializes in the manufacturing, maintenance, and support of advanced analytical laboratory instruments and precision diagnostic equipment, with deep expertise in real-time PCR systems, mass cytometers (e.g., Helios and CyTOF), and biomarker detection platforms. The company provides mission-critical reagent kits, spare parts, and service agreements for complex instrumentation used in environmental monitoring, biomedical research, and clinical diagnostics. Their technical capabilities include calibration, preventive maintenance, firmware updates, and on-site repair of high-sensitivity analytical systems, ensuring regulatory compliance and uninterrupted operation in federal laboratories. They also deliver specialized training for mass cytometry and flow-based platforms, enabling end-user proficiency in cutting-edge cellular analysis workflows. The contractor maintains strong, recurring relationships with the Department of Health and Human Services, delivering instrument service plans and training for cytometry and imaging systems; the Environmental Protection Agency, supplying reagents and maintenance for wastewater and environmental testing platforms; and the Department of the Interior, supporting field-deployed molecular diagnostics equipment. These engagements reflect a pattern of long-term, service-oriented partnerships focused on sustaining high-precision instrumentation in mission-critical settings. Standard Biotools operates primarily under NAICS 334516, positioning itself as a niche manufacturer and service provider for analytical lab instruments used in environmental, public health, and biomedical applications. Their vertical specialization lies in supporting instruments for genomic analysis, environmental contaminant detection, and cellular phenotyping, serving government labs that require validated, traceable, and FDA- or EPA-aligned workflows. As a small business structured as a 2L entity based in South San Francisco, Standard Biotools leverages its proximity to biotech innovation hubs to deliver agile, specialized support to federal agencies. While currently holding no formal government certifications, its consistent performance across high-compliance environments demonstrates operational reliability and technical credibility within the federal science and technology procurement landscape.